Thymosin Alpha-1 Peptide Screening Form Template

Thymosin Alpha-1 (Ta1) is a thymic peptide that regulates and enhances immune function by stimulating T-cell maturation, natural killer cell activity, and dendritic cell function. It is prescribed off-label through compounding pharmacies for immune support, chronic infection recovery, and immune modulation in integrative medicine. This screening form documents immune-related symptoms and screens for autoimmune conditions, malignancy, and immunosuppressive therapy use before initiating Ta1 therapy.

4 sections
17 fields
HIPAA-ready
3 citations

Free Template

Thymosin Alpha-1 Peptide Screening Form

Preview Form Automate This Form
No account required to use template
Customize with your practice branding
Reviewed against HIPAA & DEA guidelines

Form Preview

This is how the form appears to patients. Customize with your practice name and branding.

Your Practice Name

Thymosin Alpha-1 Peptide Screening Form

Preview
1

General Patient Information

Please provide your personal information.

First Name

Jane

Last Name

Smith

Date of Birth

Can you confirm you are 18 years or older?

Height

e.g. 5'8"

Weight

e.g. 170 lbs

2

Medical History

Please answer all questions as accurately as possible. Your provider will review this information.

Are you actively taking any medications? If so, please list them.

List all current medications, dosages, and frequencies

Do you have any medication allergies? If so, please list them.

List all known drug allergies and reactions

Are you currently being treated or have you been treated for any medical conditions? If so, please list them.

List all current and past medical conditions

Have you had any past surgeries? If so, please list them.

List all surgeries and approximate dates

What is/was your sex assigned at birth?

Male

Emergency contact name and phone number

Name — (555) 000-0000

Mailing address

123 Main St, City, State, ZIP

Any other questions or concerns?

Optional — share anything else you'd like your provider to know

3

Symptoms

Select all symptoms that currently apply to you.

Which of the following symptoms are you experiencing?
4

Medical Conditions

Select all conditions that currently apply to you.

Do any of the following apply to you?

Preview only. Your live form will include your branding and e-signature capture.

Submit

Compliance & Regulatory Notes

Review these notes before deploying this form in your practice.

Thymosin Alpha-1 is not FDA-approved for general immune support and is prescribed off-label. Documented informed consent is required. See FSMB: https://www.fsmb.org

Ta1 is FDA-approved as Zadaxin in some countries. US providers should verify current FDA compounding and approval status before prescribing.

Patients with autoimmune disease may be at risk of immune flares with Ta1. Consult rheumatology or immunology guidance as appropriate.

Ta1 must be dispensed by a licensed compounding pharmacy. See FDA: https://www.fda.gov/drugs/human-drug-compounding

Want This Form Automated?

Karpa Health turns static intake forms into a fully automated clinical workflow. Branded, HIPAA-compliant, and connected to compounding pharmacies.

  • Branded intake on your website
  • AI contraindication screening
  • One-click prescribing to pharmacies
  • Automated refill management
  • E-signatures and HIPAA audit trail
  • 50-state provider network included
Book a Demo

Free 30-minute walkthrough

Sources & References

  1. FDA Human Drug Compounding Guidance
  2. FSMB Off-Label Prescribing Guidelines
  3. NIH - Thymosin Alpha-1 Immunomodulation

Frequently Asked Questions

What conditions benefit most from Thymosin Alpha-1?

Ta1 is used for immune enhancement in patients with chronic or recurrent infections, post-viral fatigue, and impaired immune recovery. It has been studied extensively for hepatitis B/C, cancer immunotherapy support, and general immune modulation.

Is Thymosin Alpha-1 safe for autoimmune patients?

Autoimmune disease is a relative contraindication. While Ta1 has been used in some autoimmune contexts, its immune-stimulating properties could potentially worsen autoimmune activity. Specialist evaluation is recommended.